Morgan Stanley's unique fee-based revenue model makes it resilient to volatile interest rates. Check out why I think MS stock ...

Morgan Stanley’s diverse business model has positioned it well among its peers in the financial services industry. The company has shown leadership in year-over-year increases in markets and ...

Global brokerage firm Morgan Stanley has revised its target for the BSE Sensex to 82,000, reduced from 93,000, indicating an expected upside potential of 9% by December 2025. Morgan Stanley analysts ...

Morgan Stanley has reiterated bullish view on India's market but cut the Sensex target by 11000 to 82000 (earlier 93000). The target is still 9 per cent higher from the current level.

Morgan Stanley's Q1 2025 results show a 17% revenue increase and higher EPS, surpassing market expectations despite credit ...

Morgan Stanley beat first-quarter profit estimates on Friday, helped by record equity trading and strong wealth management ...

Morgan Stanley lowers Sensex target due to tariff uncertainties; see key stock-picking strategies and economic outlook.

Morgan Stanley surpassed first-quarter profit expectations thanks to record equity trading and robust wealth management ...

US President Donald Trump's decision to impose hefty tariffs on major economies and the launch of China's generative AI model ...

The bull case, which carries a 30 per cent probability, sees the Sensex reaching 91,000 by December 2025. This would require oil prices to remain below USD 70 per barrel, leading to lower inflation in ...

(Reuters) - Morgan Stanley beat first-quarter profit estimates on strength in equity trading and wealth management, sending ...

Morgan Stanley lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $8 from $10 and keeps an Equal Weight rating on the ...